Cancer immunotherapy via synergistic coactivation of myeloid receptors CD40 and Dectin-1
- 24 November 2023
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 8 (89) , eadj5097
Abstract
Myeloid cells facilitate T cell immune evasion in cancer yet are pliable and have antitumor potential. Here, by cotargeting myeloid activation molecules, we leveraged the myeloid compartment as a therapeutic vulnerability in mouse models of pancreatic cancer. Myeloid cells in solid tumors expressed activation receptors including the pattern recognition receptor Dectin-1 and the TNF receptor superfamily member CD40. In mouse models of checkpoint inhibitor–resistant pancreatic cancer, coactivation of Dectin-1, via systemic β-glucan therapy, and CD40, with agonist antibody treatment, eradicated established tumors and induced immunological memory. Antitumor activity was dependent on cDC1s and T cells but did not require classical T cell–mediated cytotoxicity or blockade of checkpoint molecules. Rather, targeting CD40 drove T cell–mediated IFN-γ signaling, which converged with Dectin-1 activation to program distinct macrophage subsets to facilitate tumor responses. Thus, productive cancer immune surveillance in pancreatic tumors resistant to checkpoint inhibition can be invoked by coactivation of complementary myeloid signaling pathways.Keywords
This publication has 62 references indexed in Scilit:
- A Phase I Study of an Agonist CD40 Monoclonal Antibody (CP-870,893) in Combination with Gemcitabine in Patients with Advanced Pancreatic Ductal AdenocarcinomaClinical Cancer Research, 2013
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus GemcitabineNew England Journal of Medicine, 2013
- Genome engineering using the CRISPR-Cas9 systemNature Protocols, 2013
- Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 AxisClinical Cancer Research, 2013
- Macrophages in Tumor Microenvironments and the Progression of TumorsJournal of Immunology Research, 2012
- Pattern Recognition Receptors and InflammationCell, 2010
- Signalling through C-type lectin receptors: shaping immune responsesNature Reviews Immunology, 2009
- Stimulation of dendritic cells via the dectin-1/Syk pathway allows priming of cytotoxic T-cell responsesBlood, 2008
- Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen productionBlood, 2005
- Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient miceNature, 1994